How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products

MeSH terms

• ABO Blood-Group System / genetics
• ABO Blood-Group System / immunology*
• Acute Kidney Injury / etiology
• Acute Kidney Injury / therapy
• Anemia, Hemolytic / etiology*
• Anemia, Hemolytic / immunology
• Blood Group Incompatibility / etiology*
• Blood Group Incompatibility / immunology
• Blood Group Incompatibility / prevention & control
• Complement C3 / analysis
• Coombs Test
• Erythrocyte Transfusion
• Fatal Outcome
• Female
• Hematopoietic Stem Cell Transplantation
• Humans
• Immunoglobulin G / blood
• Immunoglobulin G / immunology
• Isoantibodies / blood
• Isoantibodies / immunology
• Leukemia, Myeloid, Acute / immunology
• Leukemia, Myeloid, Acute / therapy
• Lymphocyte Transfusion
• Middle Aged
• Organizational Policy
• Plasma / immunology*
• Platelet Transfusion / adverse effects*
• Platelet Transfusion / methods
• Platelet Transfusion / standards
• Plateletpheresis / methods*
• Postoperative Complications / etiology*
• Postoperative Complications / immunology
• Renal Dialysis
• Risk Reduction Behavior
• Transplantation, Homologous / immunology